US 20120083450A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0083450 A1 Phillips, II (43) Pub. Date: Apr. 5, 2012 (54) CEREBROPROTEIN HYDROLYSATE FOR (52) U.S. Cl. ....................................................... 514/17.7 TREATING BRAIN INJURIES AND (57) ABSTRACT NEURODEGENERATIVE CONDITIONS EFFECTING THE BRAIN Cerebroprotein hydrolysate is administered intravenously and/or orally to help treat a range of brain injuries and neu rodegenerative conditions effecting the brain including Trau (76) Inventor: Douglas James Phillips, II, matic Brain Injury (TBI), concussions, injuries resulting from Tequesta, FL (US) automobile accidents, sports injuries, falls that impact the head, accidents and acts of violence that impact the head and brain including injuries incurred from combat related activi (21) Appl. No.: 12/896,002 ties, Alzheimer's disease, Parkinson's disease, Multiple Scle rosis, and other neurological conditions that adversely effect the function of the brain and central nervous system. The types of brain injuries and neurodegenerative conditions that may be treated with cerebroprotein hydrolysate range from mild to severe. Cerebroprotein hydrolysate treatment effec tively assists the brain in rebuilding neurons, synapses, and (51) Int. Cl. neurological tissue by infusing the brain with specific pro A6 IK 38/02 (2006.01) teins, neuropeptides, and amino acids to assist with brain A6IP 25/28 (2006.01) repair. (22) Filed: Oct. 1, 2010 Publication Classification